Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cationic Lipids
80%
Lung Cancer Patients
80%
P53 Gene Therapy
80%
Aerosolized
80%
Gene Complexes
60%
Human Bronchial Epithelia
50%
Bronchial Epithelium
40%
Aerosolization
40%
Lung Cancer
40%
Aerosol
40%
Phase I Clinical Trial
40%
P53 Gene
40%
Inhalation Route
25%
Intratracheal Instillation
25%
Bronchial Epithelial Cells
20%
Lung Tumor
20%
Susceptible Host
20%
Inhalation
20%
Premalignancy
20%
Maximum Tolerated Dose
20%
Carcinogen
20%
Tissue Penetration
20%
Non-small Cell Lung Cancer (NSCLC)
20%
Feasible Strategy
20%
Gene Transfection
20%
Carcinoma in Situ
20%
Tumor Growth
20%
Endobronchial Tumor
20%
Endobronchial
20%
Preclinical Toxicity
20%
Potential Interaction
20%
Regional Delivery
20%
Subepithelial Lesion
20%
Chronic Inhalation
20%
Specific Intent
20%
Lung
20%
Dose-limiting Toxicity
20%
Dysplasia
20%
Particle Size
20%
Bronchial mucus
20%
Human Lung Cancer
20%
TP53 mutation
20%
Nebulizer
20%
Carcinogenesis Process
20%
Lung Carcinogenesis
20%
P53 mutant
20%
Metaplasia
20%
Mouse Model
20%
Medicine and Dentistry
Protein P53
100%
Gene Therapy
100%
Lung Cancer
100%
Bronchial Epithelium
44%
Clinical Study
33%
Tumor Progression
11%
Carcinoma in Situ
11%
Intratracheal Drug Administration
11%
Genetic Transfection
11%
Bronchus Tumor
11%
Mucus
11%
Precancerous Condition
11%
Gene Mutation
11%
Lung Tumor
11%
Carcinogen
11%
Optimal Drug Dose
11%
Dysplasia
11%
Non Small Cell Lung Cancer
11%
Metaplasia
11%
Nebulizer
11%
Lung Carcinogenesis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Protein P53
100%
Lung Cancer
100%
Clinical Study
33%
Dysplasia
11%
Metaplasia
11%
Lung Tumor
11%
Bronchus Tumor
11%
Mouse
11%
Mouse Model
11%
Tumor Growth
11%
Non Small Cell Lung Cancer
11%
Precancer
11%
Lung Carcinogenesis
11%
Nebulizer
11%
Carcinogen
11%
Carcinoma in Situ
11%
Maximum Tolerated Dose
11%